ADAM17 and COVID-19: Circulating ADAM17 (extracellular domain) showed a trend in the risk of being hospitalized for COVID-19 (OR = 1.09, 95% CI: 0.99–1.21, IVW method) but was not associated with SARS-CoV-2 infection.